Atria Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Atria Investments’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-77,915	Closed	-$392K	–	422
2015 Q3	$392K	Buy	77,915 +7,905	+11%	+$45.3K	0.05%	227
2015 Q2	$450K	Buy	70,010 +34,234	+96%	+$229K	0.05%	257
2015 Q1	$252K	Buy	35,776 +16,239	+83%	+$118K	0.03%	354
2014 Q4	$151K	Sell	19,537 -121,544	-86%	-$962K	0.02%	407
2014 Q3	$1.05M	Sell	141,081 -215,278	-60%	-$2M	0.11%	160
2014 Q2	$3.45M	Buy	356,359 +181,068	+103%	+$1.61M	0.34%	46
2014 Q1	$1.46M	Buy	175,291 +26,190	+18%	+$224K	0.15%	125
2013 Q4	$1.26M	Buy	149,101 +47,808	+47%	+$403K	0.13%	143
2013 Q3	$807K	Buy	+101,293	New	+$814K	0.08%	202

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atria Investments's PDLI Position: Q4 2015 in Review

Atria Investments sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 77,915 shares — an estimated $392K sold.

Atria Investments first reported a position in PDLI in Q3 2013 and held it in 9 quarters. The position peaked at $3.45M in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Atria Investments reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Atria Investments sold 77,915 PDL BioPharma, Inc. shares in Q4 2015, an estimated $392K.
Atria Investments first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 9 quarters.
Atria Investments's PDL BioPharma, Inc. position peaked at $3.45M in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Atria Investments's 13F filing for Q4 2015, filed 14 Jan 2016.